Mary Sano
Overview
Explore the profile of Mary Sano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
260
Citations
10066
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramsingh N, Lin H, Ouyang Y, Ravona-Springer R, Livny A, Soleimani L, et al.
Int J Geriatr Psychiatry
. 2025 Mar;
40(3):e70060.
PMID: 40050014
Objective: To assess the relationship of subtle preclinical cognitive changes with white matter microstructure and cortical volume in middle-aged adults at high AD risk due to a parental history. Methods:...
2.
Scheltens P, Atri A, Feldman H, Hansson O, Knop F, Sano M, et al.
Neurology
. 2025 Feb;
102(7_supplement_1):3350.
PMID: 39977949
Objective: We report the preliminary baseline characteristics in the ongoing phase 3 evoke and evoke+ trials investigating the safety and efficacy of oral semaglutide for early AD. Background: Semaglutide, a...
3.
Ouyang Y, Manier D, Ravona-Springer R, Mamistalov M, Gelblum D, Heymann A, et al.
Int Psychogeriatr
. 2025 Jan;
100034.
PMID: 39863474
Objectives: Depression is a chronic disorder that significantly affects functional decline in older adults, especially those with type 2 diabetes (T2D). Ethnic groups may experience different depression risks and severities,...
4.
Cummings J, Atri A, Feldman H, Hansson O, Sano M, Knop F, et al.
Alzheimers Res Ther
. 2025 Jan;
17(1):14.
PMID: 39780249
Background: Disease-modifying therapies targeting the diverse pathophysiology of Alzheimer's disease (AD), including neuroinflammation, represent potentially important and novel approaches. The glucagon-like peptide-1 receptor agonist semaglutide is approved for the treatment...
5.
Dickerson B, Atri A, Clevenger C, Karlawish J, Knopman D, Lin P, et al.
Alzheimers Dement
. 2024 Dec;
21(1):e14337.
PMID: 39713957
US clinical practice guidelines for the diagnostic evaluation of cognitive impairment due to Alzheimer's disease (AD) or a related dementia (ADRD) are two decades old. This evidence-based guideline was developed...
6.
Atri A, Dickerson B, Clevenger C, Karlawish J, Knopman D, Lin P, et al.
Alzheimers Dement
. 2024 Dec;
PMID: 39713942
US clinical practice guidelines for the diagnostic evaluation of cognitive impairment due to Alzheimer's disease (AD) or AD and related dementias (ADRD) are decades old and aimed at specialists. This...
7.
Atri A, Dickerson B, Clevenger C, Karlawish J, Knopman D, Lin P, et al.
Alzheimers Dement
. 2024 Dec;
21(1):e14335.
PMID: 39713939
US clinical practice guidelines for the diagnostic evaluation of cognitive impairment due to Alzheimer's Disease (AD) or AD and related dementias (ADRD) are decades old and aimed at specialists. This...
8.
Le Borgne J, Gomez L, Heikkinen S, Amin N, Ahmad S, Choi S, et al.
Mol Psychiatry
. 2024 Dec;
PMID: 39633006
Due to methodological reasons, the X-chromosome has not been featured in the major genome-wide association studies on Alzheimer's Disease (AD). To address this and better characterize the genetic landscape of...
9.
Zhu C, Choi J, Hung W, Sano M
J Am Geriatr Soc
. 2024 Aug;
72(11):3360-3373.
PMID: 39166851
Introduction: Racial and ethnic disparities in potentially inappropriate medication (PIM) use among older adults with dementia are unclear. Methods: Data were drawn from the baseline visits of participants who were ...
10.
Meaningful benefit of disease-modifying treatment: Evaluating changes in health-related resource use
Zhu C, Sano M
Alzheimers Dement (N Y)
. 2024 Aug;
10(3):e12455.
PMID: 39086734
Introduction: Are reductions in the rate of decline from the new disease-modifying treatments (DMTs) in early Alzheimer's disease (AD) meaningful? We examined whether such reductions may be reflected in changes...